
August 16, 2021
RegMed Investors’ (RMi) closing bell: starting the week, the cell and gene therapy sector exhibits an irregular pulse and heartbeat
July 1, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector bounces after Wednesday’s slight slippage
June 30, 2021
RegMed Investors’ (RMi) pre-open: last trading day of 1st half, June and Q2
June 14, 2021
RegMed Investors’ (RMi) closing bell: winner, winner, chicken dinner
June 4, 2021
RegMed Investors’ (RMi) closing bell: depths and peaks as experienced by the week
June 3, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy pricing action sprung a hole in the dike
June 2, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy trips over the falling sentiment
May 20, 2021
RegMed Investors’ (RMi) pre-open: chances of recouping some value
May 6, 2021
RegMed Investors’ (RMi) closing bell: another moves to a sector downside
May 5, 2021
RegMed Investors’ (RMi) closing bell: the sector bounce-back was stifled by the close
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors